cyproterone acetate has been researched along with endothelin-1 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Matteis, A; Di Paolo, B; Franco, G; Guidi, A; Revoltella, RP | 1 |
Cerquetani, E; Fini, M; Leonardo, F; Onorati, D; Rosano, GM; Rossini, P; Vitale, C | 1 |
Charitidou, C; Farmakiotis, D; Hatzistilianou, M; Karamanis, N; Katsikis, I; Panidis, D; Pegiou, T; Pidonia, I; Zournatzi, V | 1 |
2 trial(s) available for cyproterone acetate and endothelin-1
Article | Year |
---|---|
Effect of estradiol valerate alone or in association with cyproterone acetate upon vascular function of postmenopausal women at increased risk for cardiovascular disease.
Topics: Brachial Artery; Coronary Artery Disease; Cross-Over Studies; Cyproterone Acetate; Double-Blind Method; Drug Administration Schedule; Endothelin-1; Endothelium, Vascular; Estradiol; Estrogens, Conjugated (USP); Female; Forearm; Hormone Replacement Therapy; Humans; Middle Aged; Postmenopause; Progesterone Congeners; Regional Blood Flow; Treatment Outcome | 2001 |
The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Arginine; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Endothelin-1; Estradiol; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hormones; Humans; Insulin Resistance; Polycystic Ovary Syndrome | 2008 |
1 other study(ies) available for cyproterone acetate and endothelin-1
Article | Year |
---|---|
Endothelin-1 in human prostatic carcinoma treated with androgen withdrawal: an immunohistochemical study.
Topics: Aged; Antineoplastic Agents, Hormonal; Cyproterone Acetate; Endothelin-1; Goserelin; Humans; Immunoenzyme Techniques; Leuprolide; Male; Middle Aged; Prostatectomy; Prostatic Neoplasms; Receptors, Androgen; Treatment Outcome | 2001 |